Rybelsus 14mgRybelsus 14mg
Product Price in USD
Description
Rybelsus 14mg (Semaglutide)
Rybelsus 14mg is a prescription medication primarily used to improve blood sugar control in adults with type 2 diabetes mellitus. It contains the active ingredient semaglutide, which belongs to the class of drugs known as GLP-1 receptor agonists. Manufactured by Novo Nordisk, Rybelsus is the first oral GLP-1 therapy, offering patients a convenient tablet option instead of injections for diabetes management.
Mechanism of Action
Semaglutide acts by mimicking the natural hormone GLP-1 (glucagon-like peptide-1). It helps regulate blood glucose through:
-
Stimulating insulin secretion when blood sugar is elevated
-
Reducing glucagon secretion, which lowers glucose production in the liver
-
Slowing gastric emptying to control post-meal glucose spikes
-
Suppressing appetite, promoting weight loss
These effects combine to improve blood sugar control and support overall diabetes management.
Indications
Rybelsus 14mg is indicated for:
Type 2 Diabetes Mellitus:
-
To improve glycemic control in adults whose blood sugar is not adequately managed with diet and exercise alone.
-
Not indicated for type 1 diabetes or diabetic ketoacidosis.
Dosage and Administration
Rybelsus 14mg is taken once daily and is considered the highest maintenance dose after the introductory 3mg and intermediate 7mg doses. This dosage provides maximum efficacy in blood sugar control for most patients.
Administration guidelines:
-
Take on an empty stomach, at least 30 minutes before eating, drinking, or taking other oral medications.
-
Swallow the tablet whole with no more than 4 ounces of plain water.
-
Do not crush, split, or chew the tablet.
Related Products
You may also like…
-
Tramadol
$4.00 / Per Pill -
Gabapentin 400mg
$1.00 / Per Pill -
Tadaga Super 60mg
$2.00 / Per Pill -
Lovegra 100mg
$1.50 / Per Pill




